Angelini Pharma Signs Exclusive Option Agreement With Sovargen To License Global Development and Commercialization Rights For Innovative Brain Health Asset
Angelini Pharma secures exclusive option to license global development and commercialization rights for SVG1051, a pre-clinical investigational novel compound with broad potential to treat brain
Coventry Celebrates the Power, Flexibility, and Value of Life Insurance During Life Insurance Awareness Month
FORT WASHINGTON, Pa., Sept. 22, 2025 (GLOBE NEWSWIRE) — Coventry, the leader and creator of the secondary market for life insurance, is proud to recognize
Axi Announces Retirement of Chief Commercial Officer Louis Cooper
Louis Cooper Chief Commercial Officer Axi ( CCO) Louis Cooper Chief Commercial Officer Axi ( CCO) SYDNEY, Sept. 22, 2025 (GLOBE NEWSWIRE) — Axi, a
OPEC Fund mobilizes over US$1 billion to advance sustainable development
Governing Board approves major financing package as institution launches inaugural Euro benchmark bond OPEC Fund President Abdulhamid Alkhalifa OPEC Fund President Abdulhamid Alkhalifa VIENNA, Sept.
SOC DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Sable Offshore Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 26 Deadline in Securities Class Action First Filed by the Firm – SOC
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sable Offshore Corp.
RXST DEADLINE TOMORROW: ROSEN, LEADING INVESTOR COUNSEL, Encourages RxSight, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 22 Deadline in Securities Class Action – RXST
NEW YORK, Sept. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of RxSight, Inc. (NASDAQ: